Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

Completed · Phase 2 · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

The purpose of this study is to determine the efficacy and safety of BHV-7000 in participants with Major Depressive Disorder (MDD)

Key facts

Study ID
NCT06419608
Run by
Biohaven Therapeutics Ltd.
People needed
336
Starts
2024-05-28
Expected to finish
2025-11-07
Last updated by the study team
2026-01-07

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.